Imedex, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Imedex, LLC designates this educational activity for a maximum 10.5 of AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with
the extent of their participation in
the activity.
Who Should Attend
This educational activity is specifically designed for medical and radiation oncologists, gastroenterologists, colorectal surgeons, physicians enrolled in fellowship training programs in gastrointestinal oncology and other healthcare professionals (gastroenterology and oncology nurses) in active clinical practice who wish to review and update their knowledge and management of colorectal cancer.
Objectives
After successful completion of this course, attendees should be able to:
- Comment on the latest developments in our understanding of colorectal tumor biology
- Identify challenges related to screening and surveillance of colorectal cancer patients
- Discuss state-of-the-art surgical and staging procedures for colon and rectal cancer
- Select the most appropriate adjuvant regimens for patients with colon and rectal cancer
- Describe a systematic continuum of care for patients with advanced disease including selecting the most appropriate first and second line chemotherapy regimens
- Discuss supportive care issues in the management of colorectal cancer patients, including chemotherapy-induced neurotoxicity and EGFR dermatologic toxicity
- Identify promising new agents in the treatment of colorectal cancer
- Describe and evaluate tests to identify genes that may predict benefit of chemotherapy and likelihood of recurrence for colon cancer
David A. Ahlquist, MD
Mayo Clinic
Rochester, Minnesota
Timothy J. Akhurst, MD
Memorial Sloan-Kettering Cancer Center
New York, New York
Nancy N. Baxter, MD, PhD, FRCSC
University of Toronto St. Michael’s Hospital
Toronto, Ontario, Canada
Michael A. Choti, MD
The John Hopkins University School of Medicine
Baltimore, Maryland
Francis M. Giardiello, MD
The John Hopkins University School of Medicine
Baltimore, Maryland
Richard M. Goldberg, MD
Lineberger Comprehensive Cancer Center
Chapel Hill, North Carolina
Nadim G. Haddad, MD
Georgetown University Hospital
Washington, District of Columbia
Paul R. Helft, MD
Indiana University School of Medicine
Indianapolis, Indiana
Mario E. Lacouture, MD
Northwestern University
Henry T. Lynch, MD
Creighton University School of Medicine
Omaha, Nebraska
John L. Marshall, MD
Georgetown University
Washington, District of Columbia
Bruce D. Minsky, MD
University of Chicago Medical Center
Chicago, Illinois
Mary F. Mulcahy, MD
Northwestern University
Chicago, Illinois
Heidi Nelson, MD
Mayo Clinic
Rochester, Minnesota
Michael Pignone, MD, MPH
Lineberger Comprehensive Cancer Center
Chapel Hill, North Carolina
Robert S. Sandler, MD, MPH
Lineberger Comprehensive Cancer Center
Chapel Hill, North Carolina
Daniel J. Sargent, PhD
Mayo Clinic
Rochester, Minnesota
To download the conference presentations, click the topic and/or presenter name.
Friday, August 7, 2009
8:00 am
Welcome and introduction
Richard M. Goldberg, MD
Session I: Biology and pathogenesis
8:10 am
Cell signaling in
colorectal cancer
Francis M. Giardiello, MD
8:30 am
Genetics of colorectal cancer: Hereditary aspects
Henry T. Lynch, MD
8:50 am
Panel discussion
Session II: Screening and prevention
9:10 am
Effective techniques to improve colon cancer screening in practice
Michael Pignone, MD, MPH
9:30 am
Colorectal cancer: Do health habits matter and how do patients lower risk
Robert S. Sandler, MD, MPH
9:50 am
Break
10:10 am
Will virtual colonoscopy replace optical colonoscopy for colorectal cancer
Daniel R. Swerdlow, MD
10:30 am
Noninvasive molecular detection of colorectal neoplasia: Next generation approaches
David A. Ahlquist, MD
10:50 am
Panel discussion
11:10 am
Clinical case studies and expert discussion
11:40 am
Lunch break
Concurrent Session IIIa:Colorectal surgery and staging
1:15 pm
PET scan vs. whole-body CT scan in the preoperative staging of colorectal cancer
Timothy J. Akhurst, MD
1:35 pm
Advances in colorectal surgery
Nancy N. Baxter, MD, PhD, FRCSC
1:55 pm
Staging of rectal cancer: MRI versus Ultrasound
Nadim G. Haddad, MD
2:15 pm
Altering outcomes: Interventions for hepatic metastases
Michael A. Choti, MD
2:35 pm
Panel discussion
2:55 pm
Break
Concurrent Session IIIb: Symptom management and supportive care
1:15 pm
Diarrhea: Identifying who’s at increased risk and offering the appropriate management
Mary F. Mulcahy, MD
1:40 pm
Optimizing the treatment strategies for chemotherapy-induced neurotoxicity
Charles Loprinzi, MD
2:05 pm
Mechanisms and management of EGFR inhibitor-associated dermatologic toxicities
Mario E. Lacouture, MD
2:30 pm
Panel discussion
2:50 pm
Break
Session IV: Adjuvant treatment for rectal cancer
3:15 pm
Optimizing standards in the surgical management of rectal cancer
Heidi Nelson, MD
3:35 pm
Perioperative adjuvant chemo-radio-immuno therapy for locally advanced rectal cancer
A. William Blackstock, Jr., MD
3:55 pm
Adjuvant radiation therapy for rectal cancers: Evidence from randomized trials and applications to practice
Bruce D. Minsky, MD
4:15 pm
Panel discussion
4:35 pm
Closing remarks
Richard M. Goldberg, MD and John L. Marshall, MD
4:40 pm
Adjourn
Saturday, August 8, 2009
8:00
am
Introduction
John L. Marshall, MD
Session V: Adjuvant Therapy
8:10 pm
Currently available adjuvant treatment of stage II/III colon cancer
John Marshall, MD
8:30 am
Q&A
8:40 am
Clinical and molecular features guiding us in adjuvant therapy
Daniel J. Sargent, PhD
9:00 am
Q&A
9:10 am
Clinical case studies and expert discussion
9:40 am
Break
Session VI:
Metastatic colorectal cancer I
10:00 am
Frontline chemotherapy for metastatic colorectal cancer
Richard M. Goldberg, MD
10:40 am
Systematic continuation of care: Second and third-line treatment for metastatic colorectal cancer
Paul R. Helft, MD
11:05 am
Predicting survival in metastatic colorectal cancer
Daniel J. Sargent, PhD
11:30 am
Panel discussion
11:50 am
Lunch break
Session VII:
Metastatic colorectal cancer II
1:15 pm
Antiangiogenic therapy for colorectal cancer
Al B. Benson, III, MD, FACP
1:40 pm
Targeting EGFR: Implications in colorectal cancer management
Al B. Benson, III, MD, FACP
2:05 pm
Bringing new agents
to the clinic
John L. Marshall, MD
2:30 pm
Clinical case studies and expert discussion
3:00 pm
Panel discussion
3:20 pm
Closing remarks
Richard M. Goldberg, MD and John L. Marshall, MD
3:30 pm
Adjourn
Challenging cases are being solicited to complement the scientific agenda for the 10th Annual Perspectives in Colorectal Cancer (affiliated with the World Congress on Gastrointestinal Cancer), scheduled for August 7-8, 2009 in Chicago.
Accepted cases will be published in the conference summary book and may be considered for oral presentation by the author. Authors will also receive complimentary conference registration to The 10th Annual Perspectives in Colorectal Cancer featuring an expert faculty and a comprehensive, state-of-the-art scientific program.
Cases may be submitted in the following general areas:
1) screening and prevention in colorectal cancer
2) adjuvant therapy for locally advanced colon cancer
3) metastatic colorectal cancer
Submit written cases as Word document in an attachment to an email to Theresa Jones at t.jones@imedex.com.
Deadline for submissions is July 13, 2009.
Notification of acceptance will be sent on July 20, 2009.
295
Regular Physician
Payment received by July 30, 2009
$395
Full/Onsite Physician
Payment received after July 30, 2009
-$50 Group discount (Physicians only)
Cannot be combined with any other discounts
$75 Nurses/Residents/Students
Proof of eligibility must accompany registration
To Register: You may register online by July 30, 2009 orcall Imedex at +1 (678) 242 0906. Registration confirmations will be issued before the meeting.
To qualify for special registration fees, registration and full payment must be received by Imedex by the dates specified.
The Registration and Information Desk at the InterContinental Chicago will be staffed:
Friday, August 7, 2009
7:00 am – 4:40 pm
Saturday, August 8, 2009
7:00 am – 3:30 pm
Group Discounts: Each one of multiple registrants from the same institute or practice each receive a $50 discount off the published registration fees, provided all registration forms and payments are received together. Only one discount will apply per physician.
Payment: To pre-register, registration and payment must be received no later than July 30, 2009. Please register onsite after this date. Contact Imedex at +1 (678) 242 0906 or visit our website at www.imedex.com to ensure the course is being held as scheduled and to confirm that the meeting is not full. Registration fees must be remitted by credit card or check. Checks should be payable to Imedex. Attendee is not registered until full payment is received.
Registration Fee Inclusions: Registration fees include admittance to all scientific sessions, conference materials, processing of certificates of attendance or continuing medical education, and all event functions as specified in the program.
Cancellation: For registration fees to be refunded, written notice of cancellation must be received at meetings@imedex.com no later than July 30, 2009. The amount of registration fees remitted, minus a $75 administrative charge, will be refunded after the conference. Substitutions are accepted with written notification. No refunds will be made if notice is received after July 30, 2009.
Imedex does not accept responsibility for covering travel, accommodation or any other costs incurred by registrants in the rare event that this program should be canceled for any reason. Every effort will be made to give reasonable notice in the event of cancellation. The event agenda content is subject to change without notice.
Hotel Accommodations
InterContinental Chicago
505 North Michigan Avenue
Chicago, Illinois
Tel.: +1 (312) 944 4100
Fax: +1 (312) 944 1320
http://www.icchicagohotel.com/index.cfm
Frequently referenced in architectural tours of the city, the original 1920’s design of this world-class downtown Chicago Illinois hotel has been faithfully preserved through a series of renovations, which represent nearly a quarter-billion dollars of thoughtful investment. The end result is a charming destination, affording everything necessary for a relaxing visit. Enjoy an unrivaled array of recreational features–from the Junior-Olympic indoor pool and state-of-the-art fitness center, to three distinct food and beverage venues. Corporate travelers will appreciate high-speed Internet access, conscientious event support, and a full–service business center. Rediscover this beloved hotel in downtown Chicago, Illinois. As the only hotel with a front entrance that opens directly onto the world-famous Magnificent Mile, the InterContinental Chicago offers a luxurious setting unlike any other. Experience the perfect convergence of old-world elegance and modern sophistication.
For the convenience of attendees, a limited number of rooms have been reserved until July 7, 2009 at a discounted rate of $209 single/double occupancy, plus tax, currently at 15.4%. This rate is not guaranteed outside the conference dates or after July 7, 2009. Includes buffet breakfast for one person per room.
To reserve your room please contact the InterContinental Chicago reservations department at +1 (800) 628 2112 or +1 (312) 944 4100 or visit the hotel’s website at http://www.icchicagohotel.com/index.cfm. To receive the group rate, callers must identify themselves as being with the 10th Annual Perspectives in Colorectal Cancer group. Reservation requests received after July 7, 2009 may not be guaranteed the group rate.
NOTE: Conference
presentations can be downloaded from the "Agenda" tab.
Letter from the Chairs
Dear Colleague,
It is with great pleasure and enthusiasm that we invite you to attend the 10th Annual Perspectives in Colorectal Cancer. We are pleased to welcome John L. Marshall, MD, the Clinical Director of Oncology for Georgetown University Hospital, Associate Director for Clinical Care of the Lombardi Comprehensive Cancer Center, and Chief of the Division of Hematology-Oncology, as our new Co-Chair for this meeting. Dr. Marshall specializes in cancers of the GI tract at all stages of the disease.
We are certain you will value the unique approach of this meeting in its coverage of a broad range of topics dealing with colorectal cancer. From genetics to the systematic continuum of care for patients of advanced disease, from screening to surgery and supportive care, from the optimal use of standard therapies to expert perspectives on emerging agents, the full spectrum of clinical management will be addressed.
Our ultimate goal is to provide you with the information needed to optimize care of your colorectal cancer patients and to direct your attention to those trends and evolutions that may affect your practice in the future.
We are sure you will find this meeting to be informative and enjoyable. We are looking forward to beautiful weather in August in Chicago!
Sincerely,
Richard M. Goldberg, MD
Lineberger Comprehensive Cancer Center
Chapel Hill, North Carolina
John L. Marshall, MD
Georgetown University
Washington, District of Columbia
ORGANIZER
Imedex
4325 Alexander Drive
Alpharetta, GA 30022-3740 USA
Tel.: +1 (770) 751 7332
Fax: +1 (770) 751 7334
Email: meetings@imedex.com
Web: www.imedex.com
Imedex is a brand and assumed name used by Imedex, LLC (hereby referred to as Imedex). Imedex is solely responsible for this agenda’s content. Although Imedex attempts to ensure that the information in our program is accurate and timely, matters and opinions discussed and/or presented with respect to clinical matters are those of the discussion participants only, and not necessarily those of Imedex. Moreover, although Imedex attempts to identify and integrate the most qualified medical professionals in our program, TO THE FULLEST EXTENT PERMITTED BY LAW, IMEDEX EXPRESSLY DISCLAIM ALL WARRANTIES, EITHER EXPRESS OR IMPLIED, STATUTORY OR OTHERWISE, INCLUDING BUT NOT LIMITED TO THE IMPLIED WARRANTIES OF MERCHANTABILITY, NON-INFRINGEMENT OF THIRD PARTIES’ RIGHTS, AND FITNESS FOR A PARTICULAR PURPOSE, WITH RESPECT TO THE CONTENT PRESENTED. IMEDEX FURTHER MAKES NO REPRESENTATIONS OR WARRANTIES ABOUT THE ACCURACY, RELIABILITY, COMPLETENESS OR TIMELINESS OF THE CONTENT OR ANY MATERIAL PRESENTED.
In addition, the material presented and related discussions are not intended to be medical advice, and the presentation or discussion of such material is not intended to create and does not establish a physician-patient relationship. Medical advice of any nature should be sought from an individual’s own physician.
Neither Imedex nor any of its subsidiaries or affiliates is affiliated with or formally endorsed by a medical society.
©2009 Imedex®, LLC. All rights reserved.
Reproduction in whole or part is prohibited without prior written consent from Imedex and contributing faculty.
The following companies have provided an educational grant in support of this conference:
Silver:
Genentech BioOncology
Corporate:
Several options are available to companies interested in supporting this Congress. For more information, please contact Imedex at +1(770) 751 7332, or by email at cme@imedex.com.
Opportunities are available to companies interested in exhibiting at this conference. For more information, please contact Cori Gunter at +1(678) 242 0712 or by email at c.gunter@imedex.com.
